Fitzgerald, MD, assistant professor in the department of obstetrics, gynecology and reproductive sciences in the division of urogynecology and reconstructive pelvic surgery at the University of Pittsburgh
She explains that menopausal women often show an increase of antioxidant capacity as well as lower glutathione levels along with high levels of oxidative damage. According to Tennant, this rise in antioxidant capacity may be compensatorya protective response as the body ramps up defenses to counteract mounting oxidative stress.Since glutathione levels decrease while oxidative stress increases, its reasonable to consider supplementing with glutathione or NAC, alongside lifestyle interventions like exercise, diet, sleep, stress management, and possibly hormone replacement therapy, Tennant says
IGF-1 LR3 Administration Due to the lack of data from clinical research and the fact that IGF-1 LR3 is not an approved amino acid analog of insulin-like growth factor 1 for human use, there are no official recommendations on how and where to inject it
CJC-1295 already acts on the GHRH receptor (the same receptor Sermorelin targets) but with a longer functional duration
It was studied as a provocative diagnostic test of pituitary GH-secretory capacity and as a treatment for children with idiopathic growth-hormone deficiency, where daily bedtime injection increased height velocity in some patients
